NG101

· Neurogastrx, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NG101, covering 2025-08-28 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration [Phase 1, Phase 2]